Gene · 3981
Papers3,259
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 3,259
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Prenatal identification of an inverted duplicated 13q marker chromosome with a neocentromere. | Mol Cytogenet | 2023 | 38031124 | PubTator, text mining | PubMed |
| Extrachromosomal DNA (ecDNA): Unveiling its role in cancer progression and implications for early detection. | Heliyon | 2023 | 38027570 | PubTator, text mining | PubMed |
| Hedgehog signaling and the glioma-associated oncogene in cancer radioresistance. | Front Cell Dev Biol | 2023 | 38020914 | PubTator, text mining | PubMed |
| Cas9 is mostly orthogonal to human systems of DNA break sensing and repair. | PLoS One | 2023 | 38019812 | PubTator, text mining | PubMed |
| Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. | J Exp Clin Cancer Res | 2023 | 38012734 | PubTator, text mining | PubMed |
| Unravelling the genetic variability of host resilience to endo- and ectoparasites in Nellore commercial herds. | Genet Sel Evol | 2023 | 37990289 | PubTator, text mining | PubMed |
| Repression of LSD1 potentiates homologous recombination-proficient ovarian cancer to PARP inhibitors through down-regulation of BRCA1/2 and RAD51. | Nat Commun | 2023 | 37973845 | PubTator, text mining | PubMed |
| Insights into the radiotherapy-induced deferentially expressed RNAs in colorectal cancer management. | Iran J Basic Med Sci | 2023 | 37970448 | PubTator, text mining | PubMed |
| Intratumoral androgen biosynthesis associated with 3β-hydroxysteroid dehydrogenase 1 promotes resistance to radiotherapy in prostate cancer. | J Clin Invest | 2023 | 37966114 | PubTator, text mining | PubMed |
| A Biallelic Variant of the RNA Exosome Gene EXOSC4 Causes Translational Defects Associated with a Neurodevelopmental Disorder. | medRxiv | 2023 | 37961665 | PubTator, text mining | PubMed |
| Targeting the DNA Damage Response for Cancer Therapy. | Int J Mol Sci | 2023 | 37958890 | PubTator, text mining | PubMed |
| Advancements and Obstacles of PARP Inhibitors in Gastric Cancer. | Cancers (Basel) | 2023 | 37958290 | PubTator, text mining | PubMed |
| SARS-CoV-2 and the DNA damage response. | J Gen Virol | 2023 | 37948194 | PubTator, text mining | PubMed |
| TDP1 suppresses chromosomal translocations and cell death induced by abortive TOP1 activity during gene transcription. | Nat Commun | 2023 | 37945566 | PubTator, text mining | PubMed |
| Applications of advanced technologies for detecting genomic structural variation. | Mutat Res Rev Mutat Res | 2023 | 37931775 | PubTator, text mining | PubMed |
| To investigate the mechanism of Yiwei Decoction in the treatment of premature ovarian insufficiency-related osteoporosis using transcriptomics, network pharmacology and molecular docking techniques. | Sci Rep | 2023 | 37923747 | PubTator, text mining | PubMed |
| POLE3 is a repressor of unintegrated HIV-1 DNA required for efficient virus integration and escape from innate immune sensing. | Sci Adv | 2023 | 37922361 | PubTator, text mining | PubMed |
| Interplay between the DNA damage response and the life cycle of DNA tumor viruses. | Tumour Virus Res | 2023 | 37918513 | PubTator, text mining | PubMed |
| Uncovering the Molecular Drivers of NHEJ DNA Repair-Implicated Missense Variants and Their Functional Consequences. | Genes (Basel) | 2023 | 37895239 | PubTator, text mining | PubMed |
| DNA Double-Strand Break Response and Repair Gene Polymorphisms May Influence Therapy Results and Prognosis in Head and Neck Cancer Patients. | Cancers (Basel) | 2023 | 37894339 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3981/papers?page=8